← Back to headlines
Moderna Stock Rises on Positive Cancer Vaccine Trial Results
Moderna's stock experienced a significant surge following the release of positive trial data for its cancer vaccine. The promising results have boosted investor confidence in the company's oncology pipeline.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
U.S. Officials Revise Claims Regarding Chinese Cyberattacks on Government Agencies
2h ago
AI Demand Fuels Record Chipmaker Profits Amid Broader Cost Pressures
5h ago
Rockstar Unveils Grand Theft Auto VI Details Ahead of Major Release
5h ago
Nvidia Reports Record Earnings and Raises Revenue Forecast Amid AI Demand Surge
5h ago